Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Turquie And NotGiovanni Fabbrini

List of bibliographic references

Number of relevant bibliographic references: 27.
Ident.Authors (with country if any)Title
000051 O Uzhan Zengi [Turquie] ; Alpaslan Karakas [Turquie] ; Ufuk Ergun [Turquie] ; Mehmet Senes [Turquie] ; Levent Inan [Turquie] ; Dogan Yucel [Turquie]Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer’s disease
000127 Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; P Nar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study
000361 Paolo Barone [Italie] ; Dag Aarsland [Norvège] ; David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Jaime Kulisevsky [Espagne] ; Daniel Weintraub [États-Unis]Cognitive impairment in nondemented Parkinson's disease
000362 Kolbjorn Bronnick [Norvège] ; Murat Emre [Turquie] ; Sibel Tekin [États-Unis] ; Siri B. Haugen [Norvège] ; Dag Aarsland [Norvège]Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease
000549 Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study
000811 D. Uluduz ; Ö. Ertürk ; G. Kenangil ; S. Özekmekçi ; S. Ertan ; H. Apaydin ; E. Erginöz [Turquie]Apraxia in Parkinson’s disease and multiple system atrophy
000977 Dagmar Verbaan [Pays-Bas] ; Stephanie M. Van Rooden [Pays-Bas] ; Martine Visser [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Murat Emre [Turquie] ; Jacobus J. Van Hilten [Pays-Bas]Psychotic and compulsive symptoms in Parkinson's disease
000A48 A. H. V. Schapira [Royaume-Uni] ; M. Emre [Turquie] ; P. Jenner [Royaume-Uni] ; Werner Poewe [Autriche]Levodopa in the treatment of Parkinson’s disease
000C23 I. Midi [Turquie] ; M. Dogan [Turquie] ; M. Koseoglu [Turquie] ; G. Can [Turquie] ; M. A. Sehitoglu [Turquie] ; D. I. Gunal [Turquie]Voice abnormalities and their relation with motor dysfunction in Parkinson’s disease
000D15 Christopher G. Goetz [États-Unis] ; Murat Emre [Turquie] ; Bruno Dubois [France]Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis
000E09 Nazmiye Cakmak [Turquie] ; Nurten Sayar [Turquie] ; Mahmut Cakmak [Turquie] ; Ahmet Akyol [Turquie] ; Enis Oguz [Turquie] ; Abdurrahman Eksik [Turquie] ; Ahmet Taha Alper [Turquie] ; Hakan Hasdemir [Turquie] ; Hale Yilmaz [Turquie] ; Izzet Erdinler [Turquie]Effects of Radiofrequency Catheter Ablation on Myocardial Performance Index and Plasma NT‐Pro‐BNP Levels in Patients with Wolff‐Parkinson‐White Syndrome
000F24 Ebru Mihci [Turquie] ; Babür Dora [Turquie] ; Sevin Balkan [Turquie]Transcranial doppler ultrasonographic evaluation of cerebral circulation during passive tilting in patients with Parkinson's disease
000F48 Uwe Ehrt [Norvège] ; Kolbj Rn Br Nnick [Norvège] ; Peter Paul De Deyn [Belgique] ; Murat Emre [Turquie] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis] ; Dag Aarsland [Norvège]Subthreshold depression in patients with Parkinson's disease and dementia––clinical and demographic correlates
000F68 G. Waldemar [Danemark] ; B. Dubois [France] ; M. Emre [Turquie] ; J. Georges [Luxembourg (pays)] ; I. G. Mckeith [Royaume-Uni] ; M. Rossor [Royaume-Uni] ; P. Scheltens [Pays-Bas] ; P. Tariska [Hongrie] ; B. Winblad [Suède]Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
000F80 Kolbjorn Bronnick [Norvège] ; Murat Emre [Turquie] ; Roger Lane [États-Unis] ; Sibel Tekin [États-Unis] ; Dag Aarsland [Norvège]Profile of cognitive impairment in dementia associated with Parkinson’s disease compared with Alzheimer’s disease
001075 Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
001098 Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France]Clinical diagnostic criteria for dementia associated with Parkinson's disease
001166 Fatih Bayrak [Turquie] ; Evrim Komurcu-Bayrak [Turquie] ; Bulent Mutlu [Turquie] ; Gokhan Kahveci [Turquie] ; Yelda Basaran [Turquie] ; Nihan Erginel-Unaltuna [Turquie]Ventricular pre‐excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation
001341 David B. Rivers [États-Unis] ; Fevzi Uckan [Turquie] ; Ekrem Ergin [Turquie]Characterization and biochemical analyses of venom from the ectoparasitic wasp Nasonia vitripennis (Walker) (hymenoptera: Pteromalidae)
001342 Guido Alves [Norvège] ; Jan Petter Larsen [Norvège] ; Murat Emre [Turquie] ; Tore Wentzel-Larsen [Norvège] ; Dag Aarsland [Norvège]Changes in motor subtype and risk for incident dementia in Parkinson's disease
001399 Hasmet A. Hanagasi ; Murat Emre [Turquie]Treatment of behavioural symptoms and dementia in Parkinson's disease
001423 D. Kaynak ; G. Kiziltan ; H. Kaynak ; G. Benbir ; O. Uysal [Turquie]Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment
001513 Jordi Clarimon [États-Unis] ; Janel Johnson [États-Unis] ; Okan Dogu [Turquie] ; Wagner Horta [Brésil] ; Naheed Khan [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; John Hardy [États-Unis] ; Andrew Singleton [États-Unis]Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease
001598 Robert Hering [Allemagne] ; Karsten M. Strauss [Allemagne] ; Xiao Tao [États-Unis] ; Andreas Bauer [Allemagne] ; Dirk Woitalla [Allemagne] ; Eva-Maria Mietz [Allemagne] ; Slobodanka Petrovic [Allemagne] ; Peter Bauer [Allemagne] ; Wilhelm Schaible [Allemagne] ; Thomas Müller [Allemagne] ; Ludger Schöls [Allemagne] ; Christine Klein [Allemagne] ; Daniela Berg [Allemagne] ; Philipp T. Meyer [Allemagne] ; Jörg B. Schulz [Allemagne] ; Bernd Wollnik [Turquie] ; Liang Tong [États-Unis] ; Rejko Krüger [Allemagne] ; Olaf Riess [Allemagne]Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
001681 Murat Emre [Turquie]What causes mental dysfunction in Parkinson's disease?
001A24 M. Polatli [Turquie] ; A. Akyol [Turquie] ; O. Çilda [Turquie] ; K. Bayülkem [Turquie]Pulmonary function tests in Parkinson’s disease
001C16 Bedia A Açhan [Turquie] ; Hülya Y Lmaz [Turquie] ; Makbule Ayd N [Turquie] ; Turgay Isbir [Turquie]Is there any association between apolipoprotein E and angiotensin converting enzyme gene polymorphism in patients with Parkinson's disease and dementia in Turkish population?

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024